YES-6Homo sapiens (Human)Cancer cell line
Also known as: YES6, Yes-6
AI Summary
No AI-generated summary available for this cell line.
Basic Information
| Database ID | CVCL_S530 |
|---|---|
| Species | Homo sapiens (Human) |
Disease Information
| Disease | Squamous cell carcinoma of the esophagus |
|---|
DepMap Information
Publications
ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.
Jin J.-K., Ma L., Zhu H.-T., Skinner H.D., Johnson R.L., Ajani J.A.
Oncotarget 6:25883-25896(2015).
Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.
Kusukawa J., Kage M., Shirouzu K., Yamana H.
Mol. Cancer Ther. 9:1842-1851(2010).
Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
Yoshino S., Hazama S.
Oncol. Rep. 20:155-163(2008).
Expression of G1 cell cycle markers and the effect of adenovirus-mediated overexpression of p21Waf-1 in squamous cell carcinoma of the esophagus.
Morimatsu M.
Int. J. Oncol. 18:157-163(2001).
Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
Yang H.-L., Dong Y.-B., Elliott M.J., Liu T.-J., McMasters K.M.
Clin. Cancer Res. 6:1579-1589(2000).
The influence of interleukin-6 on the growth of human esophageal cancer cell lines.
Suzuki T.
J. Interferon Cytokine Res. 16:1001-1006(1996).